| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.29 | 8e-05 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.23 | 5e-05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-05 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.18 | 0.002 |